New Drugs Turned Down by EU Safety Assessor

Source link :

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given negative opinions for two drugs intended to treat amyotrophic lateral sclerosis (ALS) and age-related macular degeneration (AMD). It also recommended nonrenewal of a conditional authorization for a Duchenne muscular dystrophy medication. ALS Medicine Not Recommended At its June 2024 meeting, the […]

Author : News Health

Publish date : 2024-06-28 15:14:16

Copyright for syndicated content belongs to the linked Source.